Could wounded skin someday regrow perfectly without scars? A new study by Harvard stem cell biologists published in Cell ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...
CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...
BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...
Scientists push CAR T cell therapy beyond blood cancers, unlocking potential for targeting solid tumors with enhanced delivery, resilience, and precision in the face of tough obstacles. Study: Beyond ...
Researchers have identified Nr1h2, a critical transcription factor essential for early embryo development. Their findings enhance our understanding of gene regulation during blastoid formation and ...
Sagar Lonial, MD, discusses the expanding potential uses of cereblon E3 ligase modulators (CELMoDs) in combination with ...
The landscape of lupus treatment is rapidly evolving, bringing promising options such as CAR cell therapy and T-cell engager therapies. However, many individuals living with lupus, their caregivers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results